Timpani Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$4.29M Buy
136,167
+13,470
+11% +$392K 2.05% 12
2018
Q4
$3.08M Sell
122,697
-22,569
-16% -$580K 1.73% 15
2018
Q3
$4.19M Buy
145,266
+28,485
+24% +$533K 1.21% 35
2018
Q2
$1.43M Buy
+116,781
New +$1.34M 0.42% 75

Other funds holding CDNA

Timpani Capital Management's CDNA Position: Q1 2019 in Review

Timpani Capital Management increased its CareDx (CDNA) stake by 11% in Q1 2019, buying an estimated $392K and bringing the position to 136,167 shares worth $4.29M. The position accounts for 2.05% of the portfolio, ranked #12.

Timpani Capital Management first reported a position in CDNA in Q2 2018 and has held it in 4 quarters since. 182 funds tracked by Wall St. Rank hold CDNA as of Q1 2019.

  • Timpani Capital Management held 136,167 shares of CareDx worth $4.29M as of Q1 2019.
  • Timpani Capital Management bought 13,470 CareDx shares in Q1 2019, an estimated $392K.
  • CareDx made up 2.05% of Timpani Capital Management's portfolio in Q1 2019, its #12 holding.
  • Timpani Capital Management first reported a position in CareDx in Q2 2018 and has held it in 4 quarters since.
  • 182 funds tracked by Wall St. Rank held CareDx as of Q1 2019.

Based on Timpani Capital Management's 13F filing for Q1 2019, filed 10 May 2019.